PAVmed Inc. to Hold Business Update Conference Call on November 16th
10 November 2017 - 2:00AM
Business Wire
PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly
differentiated, multi-product medical device company, today
announced that the Company will host a conference call on Thursday,
November 16, 2017 at 4:30 p.m. Eastern time. During this call
Lishan Aklog, M.D., the Company’s Chairman and Chief Executive
Officer, will provide a business update including an overview of
the Company’s near-term milestones and growth strategy. In
addition, Dennis McGrath, the Company’s Chief Financial Officer,
will discuss third quarter 2017 financial results.
To access the conference call, U.S.-based listeners should dial
(888) 803-5993 and international listeners should dial (706)
634-5454. All listeners should provide the following passcode:
8082249. Individuals interested in listening to the live conference
call via the internet may do so by visiting the Company’s website
at www.pavmed.com.
Following the conclusion of the conference call, a replay will
be available through November 22, 2017 and can be accessed by
dialing (855) 859-2056 from within the U.S. or (404) 537-3406 from
outside the U.S. All listeners should provide passcode: 8082249.
The webcast will be available for a period of time on the Company’s
website at www.pavmed.com.
About PAVmed Inc.
PAVmed Inc. (Nasdaq:PAVM, PAVMW) is a highly differentiated,
multi-product medical device company employing a unique business
model designed to advance products from concept to
commercialization much more rapidly and with significantly less
capital than the typical medical device company. This proprietary
model enables PAVmed to pursue an expanding multi-product pipeline
strategy with a view to enhancing and accelerating value creation.
PAVmed’s diversified pipeline of products address unmet clinical
needs, have attractive regulatory pathways and market opportunities
and encompass a broad spectrum of clinical areas including carpal
tunnel syndrome (CarpX™), medical infusions (NextFlo™ and
NextCath™), interventional radiology (PortIO™ and NextCath), tissue
ablation and cardiovascular intervention (Caldus™) and pediatric
ear infections (DisappEAR™).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171109005666/en/
InvestorsLHA Investor RelationsKim
Sutton Golodetz, 212-838-3777kgolodetz@lhai.comorinfo@pavmed.comorMediaRooneyPartnersThomas Hynes,
212-223-0651thynes@rooneyco.com
PAVmed (NASDAQ:PAVMW)
Historical Stock Chart
From Apr 2024 to May 2024
PAVmed (NASDAQ:PAVMW)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about PAVmed Inc (NASDAQ): 0 recent articles
More Pavmed Inc. - Warrant (MM) News Articles